318 results
Page 15 of 16
6-K
EX-1.2
gns np0ighiod
31 Jan 06
Current report (foreign)
12:00am
424B5
fqttzs 42pfmmyir8i
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
a1ygxi2jw9f spf0wi
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
t63f5 h8tg
30 Jan 06
Prospectus supplement for primary offering
12:00am
F-3ASR
2zv6f5b3
30 Jan 06
Automatic shelf registration (foreign)
12:00am
424B5
roh1fiq
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
mzodfbn 8r4
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
w4x1 1fowkotohqs
26 Jan 06
Prospectus supplement for primary offering
12:00am
S-8
u0pjnv27kuulbaj3c gk
25 Jan 06
Registration of securities for employees
12:00am
F-3ASR
4m9 dbrrw6
20 Dec 05
Automatic shelf registration (foreign)
12:00am
F-4
xpfvohzztuc54
2 Sep 05
Registration of securities (foreign)
12:00am
6-K
o8quvcnftsmuvtuoyojj
10 Aug 05
6K Report
12:00am
6-K
EX-2.1
vdur ftn3ugxiu10m
28 Jul 05
Current report (foreign)
12:00am
S-8
fw6emskpwh19 h0mdk
30 Jun 05
Registration of securities for employees
12:00am
6-K
znor0cf
28 Jun 05
Teva and Active Biotech Announce the Submission of an Ind to the Fda for Laquinimod, an Oral Product for the Treatment of Relapsing MS
12:00am
6-K
ficw98hi
3 May 05
Teva Reports First Quarter 2005 Results
12:00am
6-K
er3jkquajw6qa509wkyu
22 Mar 05
Teva and Active Biotech Announce That Laquinimod Phase II Data Has Been Published Today In Neurology
12:00am
6-K
jqqj3bpmzq
26 Jan 05
Teva Announces Global In-market Fourth Quarter Sales of Copaxone? Increased 26% to $261 Million
12:00am
6-K
vxj3t01xrfm4drvalx
18 Nov 04
Teva and Lundbeck Announce That Azilect? (Rasagiline) for Parkinson's Disease Is Recommended for Approval In the Eu
12:00am